Original Research

Published on 14 Nov 2023

In vitro pharmacological characterization of standard and new lysophosphatidic acid receptor antagonists using dynamic mass redistribution assay

in Experimental Pharmacology and Drug Discovery

C. Ruzza
M. Argentieri
F. Ferrari
E. Armani
M. Trevisani
G. Marchini
G. Calo’

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1267414

1,784 views
1 citation

Editorial

Published on 14 Nov 2023

Editorial: Drug-ability strategies for potential antimycobacterial candidate: opportunities and challenges

in Experimental Pharmacology and Drug Discovery

Shasank Sekhar Swain
Sunday Oyedemi
Sudhir Kumar Paidesetty
Soumitra Mohanty
Tahziba Hussain

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1294912

659 views
1 citation

Editorial

Published on 13 Nov 2023

Editorial: Medicinal Cannabis: evolution of therapeutic use, future approaches and other implications, volume II

in Experimental Pharmacology and Drug Discovery

Francesca Baratta
Shimon Ben-Shabat
Paola Brusa
Massimo Collino

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1322404

728 views

Original Research

Published on 13 Nov 2023

Structure-function and rational design of a spider toxin Ssp1a at human voltage-gated sodium channel subtypes

in Experimental Pharmacology and Drug Discovery

Yashad Dongol
David T. Wilson
Norelle L. Daly
Fernanda C. Cardoso
Richard J. Lewis

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1277143

1,338 views
1 citation

Original Research

Published on 13 Nov 2023

Role of peptide–cell surface interactions in cosmetic peptide application

in Experimental Pharmacology and Drug Discovery

Bingwei He
Feifei Wang
Liping Qu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1267765

4,894 views
2 citations

Original Research

Published on 09 Nov 2023

Linagliptin and secoisolariciresinol diglucoside attenuate hyperlipidemia and cardiac hypertrophy induced by a high-methionine diet in rats via suppression of hyperhomocysteinemia-induced endoplasmic reticulum stress

in Experimental Pharmacology and Drug Discovery

Israa A. Jalal
Abeer Elkhoely
Shimaa K. Mohamed
Amany A. E. Ahmed

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1275730

1,755 views

Mini Review

Published on 09 Nov 2023

Advances in the treatment of autosomal recessive congenital ichthyosis, a look towards the repositioning of drugs

in Experimental Pharmacology and Drug Discovery

Sheila I. Peña-Corona
Stephany Celeste Gutiérrez-Ruiz
Ma de los Dolores Campos Echeverria
Hernán Cortés
Manuel González-Del Carmen
Gerardo Leyva-Gómez

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1274248

5,559 views
1 citation

Original Research

Published on 08 Nov 2023

Potential antioxidative and anti-hyperuricemic components in Rodgersia podophylla A. Gray revealed by bio-affinity ultrafiltration with SOD and XOD

in Experimental Pharmacology and Drug Discovery

Can Liang
Yongbing Xu
Minxia Fan
Felix Wambua Muema
Guilin Chen
Mingquan Guo
Guangwan Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1298049

2,068 views
1 citation

Original Research

Published on 08 Nov 2023

A novel Glycyrrhiza glabra extract liquiritin targeting NFATc1 activity and ROS levels to counteract ovariectomy-induced osteoporosis and bone loss in murine model

in Experimental Pharmacology and Drug Discovery

Guoju Hong
Lin Zhou
Guanqiang Zheng
Xiaoxia Zheng
Zhenqiu Chen
Wei He
Qiushi Wei

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1287827

1,880 views
2 citations

Original Research

Published on 07 Nov 2023

Computer-aided drug design for virtual-screening and active-predicting of main protease (Mpro) inhibitors against SARS-CoV-2

in Experimental Pharmacology and Drug Discovery

Renhui Dai
Hongwei Gao
Ruiling Su

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1288363

2,382 views
4 citations

Original Research

Published on 07 Nov 2023

Investigating the role of NPR1 in dilated cardiomyopathy and its potential as a therapeutic target for glucocorticoid therapy

in Experimental Pharmacology and Drug Discovery

Yaomeng Huang
Tongxin Li
Shichao Gao
Shuyu Li
Xiaoran Zhu
Ying Li
Dangyang Liu
Weimin Li
Linquan Yang
Kunshen Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1290253

1,432 views
2 citations

Brief Research Report

Published on 07 Nov 2023

ClickArr: a novel, high-throughput assay for evaluating β-arrestin isoform recruitment

in Experimental Pharmacology and Drug Discovery

Alexander R. French
Yazan J. Meqbil
Richard M. van Rijn

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1295518

2,249 views
3 citations

Editorial

Published on 06 Nov 2023

Editorial: New drugs, approaches, and strategies to combat antimicrobial resistance

in Experimental Pharmacology and Drug Discovery

Chandra Kant Singh
Kushneet Kaur Sodhi
Mohammad S. Mubarak

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1295623

1,460 views
8 citations

Original Research

Published on 06 Nov 2023

Pharmacokinetics and absorption mechanism of tandospirone citrate

in Experimental Pharmacology and Drug Discovery

Rong Li
Yuwen Chen
Mi Jia
Xuehua Jiang
Ling Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1283103

1,604 views
2 citations

Original Research

Published on 06 Nov 2023

Targeting PD-1/PD-L1 inhibits rejection in a heterotopic tracheal allograft model of lung transplantation

in Experimental Pharmacology and Drug Discovery

Taisuke Kaiho
Hidemi Suzuki
Atsushi Hata
Hiroki Matsumoto
Kazuhisa Tanaka
Yuichi Sakairi
Shinichiro Motohashi
Ichiro Yoshino

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1298085

1,310 views
1 citation

Review

Published on 02 Nov 2023

Association for Human Pharmacology in the Pharmaceutical Industry conference 2022: impending change, innovations and future challenges

in Experimental Pharmacology and Drug Discovery

Charles Mundy
James Bush
Joseph Cheriyan
Ulrike Lorch
Steffan Stringer
Jörg Taubel
Kirsty Wydenbach
Timothy C. Hardman

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1219591

3,261 views

Navigation group

Articles

In vitro pharmacological characterization of standard and new lysophosphatidic acid receptor antagonists using dynamic mass redistribution assay

Editorial: Drug-ability strategies for potential antimycobacterial candidate: opportunities and challenges

Editorial: Medicinal Cannabis: evolution of therapeutic use, future approaches and other implications, volume II

Structure-function and rational design of a spider toxin Ssp1a at human voltage-gated sodium channel subtypes

Role of peptide–cell surface interactions in cosmetic peptide application

Linagliptin and secoisolariciresinol diglucoside attenuate hyperlipidemia and cardiac hypertrophy induced by a high-methionine diet in rats via suppression of hyperhomocysteinemia-induced endoplasmic reticulum stress

Advances in the treatment of autosomal recessive congenital ichthyosis, a look towards the repositioning of drugs

Potential antioxidative and anti-hyperuricemic components in Rodgersia podophylla A. Gray revealed by bio-affinity ultrafiltration with SOD and XOD

A novel Glycyrrhiza glabra extract liquiritin targeting NFATc1 activity and ROS levels to counteract ovariectomy-induced osteoporosis and bone loss in murine model

Computer-aided drug design for virtual-screening and active-predicting of main protease (Mpro) inhibitors against SARS-CoV-2

Investigating the role of NPR1 in dilated cardiomyopathy and its potential as a therapeutic target for glucocorticoid therapy

ClickArr: a novel, high-throughput assay for evaluating β-arrestin isoform recruitment

Editorial: New drugs, approaches, and strategies to combat antimicrobial resistance

Pharmacokinetics and absorption mechanism of tandospirone citrate

Targeting PD-1/PD-L1 inhibits rejection in a heterotopic tracheal allograft model of lung transplantation

Association for Human Pharmacology in the Pharmaceutical Industry conference 2022: impending change, innovations and future challenges